blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1802313

EP1802313 - THERAPEUTIC AGENTS TRAGETING THE NCCA-ATP CHANNEL AND METHODS OF USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.09.2011
Database last updated on 25.09.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
University of Maryland, Baltimore
515 West Lombard Street, 5th Floor
Baltimore, MD 21201-1602 / US
For all designated states
Department of Veterans Affairs, Office of General Counsel
810 Vermont Avenue, N.W.
Washington, D.C. 20420 / US
[2007/27]
Inventor(s)01 / SIMARD, J., Marc
5223 Springlake Way
Baltimore, MD 21212-3421 / US
02 / CHEN, Mingkui
4311 Alan Drive, Apt. B
Baltimore, MD 21229 / US
 [2007/27]
Representative(s)Woods, Geoffrey Corlett
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2008/29]Woods, Geoffrey Corlett
J.A. KEMP & CO. 14 South Square Gray's Inn London
WC1R 5JJ / GB
Former [2007/27]Woods, Geoffrey Corlett
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date05805849.625.07.2005
[2007/27]
WO2005US26455
Priority number, dateUS20040610758P18.09.2004         Original published format: US 610758 P
[2007/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006036278
Date:06.04.2006
Language:EN
[2006/14]
Type: A2 Application without search report 
No.:EP1802313
Date:04.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 06.04.2006 takes the place of the publication of the European patent application.
[2007/27]
Type: B1 Patent specification 
No.:EP1802313
Date:03.11.2010
Language:EN
[2010/44]
Search report(s)International search report - published on:EP18.05.2007
ClassificationIPC:A61K31/64, A61K31/44, A61K31/40, A61K31/549, A61K31/00, A61P25/00, A61P35/00
[2007/27]
CPC:
A61K31/00 (EP,US); A61K31/64 (EP,US); A61K31/165 (EP,US);
A61K31/175 (EP,US); A61K31/37 (US); A61K31/40 (EP,US);
A61K31/44 (EP,US); A61K31/549 (EP,US); A61K31/565 (EP,US);
A61K31/566 (EP,US); A61K38/166 (US); A61K38/177 (EP,US);
A61K38/482 (EP,US); A61K38/49 (EP,US); A61K45/06 (EP,US);
A61P25/00 (EP); A61P35/00 (EP); A61P35/04 (EP);
A61P43/00 (EP); A61P9/10 (EP,US); C12Y304/21068 (US);
C12Y304/21073 (US); C07K14/4705 (US) (-)
C-Set:
A61K31/175, A61K2300/00 (US,EP);
A61K31/40, A61K2300/00 (US,EP);
A61K31/44, A61K2300/00 (US,EP);
A61K31/549, A61K2300/00 (US,EP);
A61K31/565, A61K2300/00 (EP,US);
A61K31/64, A61K2300/00 (EP,US);
A61K38/177, A61K2300/00 (EP,US);
A61K38/49, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/27]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:THERAPEUTISCHE MITTEL ZUM TARGETING DES NCCA-ATP-KANALS UND VERWENDUNGSVERFAHREN DAFÜR[2007/27]
English:THERAPEUTIC AGENTS TRAGETING THE NCCA-ATP CHANNEL AND METHODS OF USE THEREOF[2007/27]
French:AGENTS THERAPEUTIQUES CIBLANT LE CANAL NCCA-ATP ET LEURS METHODES D'UTILISATION[2007/27]
Entry into regional phase13.04.2007National basic fee paid 
13.04.2007Designation fee(s) paid 
13.04.2007Examination fee paid 
Examination procedure13.04.2007Examination requested  [2007/27]
20.06.2007Amendment by applicant (claims and/or description)
10.04.2008Despatch of a communication from the examining division (Time limit: M06)
26.11.2008Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
18.12.2008Reply to a communication from the examining division
16.01.2009Despatch of a communication from the examining division (Time limit: M06)
22.07.2009Reply to a communication from the examining division
03.08.2009Despatch of a communication from the examining division (Time limit: M06)
11.02.2010Reply to a communication from the examining division
01.04.2010Communication of intention to grant the patent
09.08.2010Fee for grant paid
09.08.2010Fee for publishing/printing paid
Divisional application(s)EP10010753.1  / EP2359832
Opposition(s)04.08.2011No opposition filed within time limit [2011/41]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
18.12.2008Request for further processing filed
18.12.2008Full payment received (date of receipt of payment)
Fees paidRenewal fee
27.07.2007Renewal fee patent year 03
25.07.2008Renewal fee patent year 04
28.07.2009Renewal fee patent year 05
26.07.2010Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.11.2010
BE03.11.2010
CY03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
HU03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
TR03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
IE25.07.2011
LU25.07.2011
MC31.07.2011
[2013/45]
Former [2013/44]AT03.11.2010
BE03.11.2010
CY03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
TR03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
IE25.07.2011
LU25.07.2011
MC31.07.2011
Former [2013/26]AT03.11.2010
BE03.11.2010
CY03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
IE25.07.2011
LU25.07.2011
MC31.07.2011
Former [2013/25]AT03.11.2010
BE03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
IE25.07.2011
LU25.07.2011
MC31.07.2011
Former [2012/35]AT03.11.2010
BE03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
IE25.07.2011
MC31.07.2011
Former [2012/11]AT03.11.2010
BE03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
MC31.07.2011
Former [2012/03]AT03.11.2010
BE03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
IT03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
Former [2011/38]AT03.11.2010
BE03.11.2010
CZ03.11.2010
DK03.11.2010
EE03.11.2010
FI03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
PL03.11.2010
RO03.11.2010
SI03.11.2010
SK03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
Former [2011/35]AT03.11.2010
BE03.11.2010
CZ03.11.2010
EE03.11.2010
FI03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
SI03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
Former [2011/32]AT03.11.2010
BE03.11.2010
FI03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
SI03.11.2010
BG03.02.2011
GR04.02.2011
ES14.02.2011
IS03.03.2011
PT03.03.2011
Former [2011/29]AT03.11.2010
FI03.11.2010
LT03.11.2010
LV03.11.2010
NL03.11.2010
SI03.11.2010
BG03.02.2011
GR04.02.2011
IS03.03.2011
PT03.03.2011
Former [2011/23]FI03.11.2010
LT03.11.2010
LV03.11.2010
IS03.03.2011
Former [2011/19]LT03.11.2010
Cited inInternational search[X]WO0154771  (CEDARS SINAI MEDICAL CENTER [US]) [X] 1-26 * claims 83-85 *;
 [X]WO03075933  (UPSHER SMITH LAB INC [US]) [X] 27-29,34* page 6, line 14 - line 22 *;
 [XD]WO03079987  (UNIV MARYLAND [US], et al) [XD] 27-106 * paragraphs [0141] , [0148]; claims 1,3,6,25-30 *;
 [X]  - YONG SOO LEE ET AL, "IN VITRO ANTITUMOR ACTIVITY OF CROMAKALIM IN HUMAN BRAIN TUMOR CELLS", PHARMACOLOGY, (1994), vol. 49, ISSN 0031-7012, pages 69 - 74, XP002948868 [X] 1-18,23-26 * the whole document *

DOI:   http://dx.doi.org/10.1159/000139218
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.